Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Start date
02 Mar 2020
End date
04 Mar 2020
Paris, France

The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.

Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients. 

The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.

Programme 1000x250


Access the online programme for TAT 2020 – Targeted Anticancer Therapies!

Meeting Resources Tablet in Hand 1000x250

Congress Coverage

All the resources from ESMO Targeted Anticancer Therapies Congress 2020: abstracts and abstract book are available.

Contacts 1000x250


Get in touch with the organisers of ESMO Targeted Anticancer Therapies Congress 2020. Contact details here

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.